Vilanterol

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

26 Suppliers, 7 USDMF, 4 EU WC, 1 KDMF, 9 NDC API, 23 Listed Suppliers

DEVELOPMENTS

11 Drug(s) in Development

11 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

10 Suppliers

10 Suppliers

DOSSIERs // Finished Dosage Forms

21 Dossiers, 6 FDA Orange Book, 12 Europe, 3 South Africa

DRUG PRODUCT COMPOSITION

POWDER;INHALATION - EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH

RELATED EXCIPIENT COMPANIES

Suppliers, 14 Kerry, 7 Microlex e.U, 5 Gangwal Healthcare, 2 DFE Pharma, 2 Sigachi Industries, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Prachin Chemical, 1 Nanjing Well Pharmaceutical, 1 Vasa Pharmachem, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

EXCIPIENTS BY APPLICATIONS

24 Fillers, Diluents & Binders, 8 Lubricants & Glidants, 7 Direct Compression, 5 Co-Processed Excipients, 4 Granulation, 1 Disintegrants & Superdisintegrants, 1 Controlled & Modified Release, 1 Emulsifying Agents, 1 Thickeners and Stabilizers, 1 Parenteral

GLOBAL SALES INFORMATION

12 Finished Drug Prices

12 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS

110 US Patents, 4 US Exclusivities, 2 Health Canada Patents

ANALYTICAL SOLUTION(s)

10 Other Ref. Standards

10 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 41 News

Information, Expiry & Status of Health Canada Patents covering Vilanterol.

Vilanterol

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

26 Suppliers

7 USDMF

4 EU WC

1 KDMF

9 NDC API

23 Listed Suppliers

DEVELOPMENTS

11 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

10 Suppliers

DOSSIERs // Finished Dosage Forms

21 Dossiers

6 FDA Orange Book

12 Europe

3 South Africa

DRUG PRODUCT COMPOSITION

POWDER;INHALATION - EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH

RELATED EXCIPIENT COMPANIES

Suppliers

14 Kerry

7 Microlex e.U

5 Gangwal Healthcare

2 DFE Pharma

2 Sigachi Industries

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Prachin Chemical

1 Nanjing Well Pharmaceutical

1 Vasa Pharmachem

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

EXCIPIENTS BY APPLICATIONS

24 Fillers, Diluents & Binders

8 Lubricants & Glidants

7 Direct Compression

5 Co-Processed Excipients

4 Granulation

1 Disintegrants & Superdisintegrants

1 Controlled & Modified Release

1 Emulsifying Agents

1 Thickeners and Stabilizers

1 Parenteral

GLOBAL SALES INFORMATION

12 Finished Drug Prices

MARKET PLACE

2 APIs

PATENTS

110 US Patents

4 US Exclusivities

2 Health Canada Patents

ANALYTICAL SOLUTION(s)

10 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow

41 News

Vilanterol

GLAXOSMITHKLINE INC

Vilanterol Trifenatate

2417825

25 mcg

Inhalation Powder

Human

2021-08-03

2008-07-22

2001-08-03

BREO ELLIPTA

Oral Inhalation

GLAXOSMITHKLINE INC

Vilanterol Trifenatate

2458534